The growth factor independence-1 (Gfi1) is overexpressed in chronic myelogenous Leukemia

Acta Haematologica

Volumn 123, Issue 1, 2009, Pages 1-5

  Huang, Min ^a   Hu, Zhenping ^a   Chang, Wei ^b   Ou, Dongmei ^a   Zhou, Jianfeng ^a   Zhang, Yicheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Department of Hematology   (China)

Author keywords

Chronic myelogenous leukemia; Expression; Growth factor independence 1

Indexed keywords

BCR ABL PROTEIN; GROWTH FACTOR INDEPENDENCE 1; IMATINIB; MESSENGER RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER PATIENT; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; WESTERN BLOTTING;

ANTIGENS, CD34; BASE SEQUENCE; BLAST CRISIS; DNA PRIMERS; DNA-BINDING PROTEINS; GENE EXPRESSION; GENES, ABL; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACCELERATED PHASE; LEUKEMIA, MYELOID, CHRONIC-PHASE; NEOPLASTIC STEM CELLS; PIPERAZINES; PYRIMIDINES; RNA, MESSENGER; RNA, NEOPLASM; STEM CELL TRANSPLANTATION; TRANSCRIPTION FACTORS;

EID: 70350532375     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000253856     Document Type: Article

References (17)

1. Druker BJ: Translation of the Philadelphia chromosome into therapy for CML. Blood 2008; 112: 4808-4817.
2. Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA: Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408-2417. (Pubitemid 44903745)
3. Hochhaus A, O'Brien SG, Guilhot F, Druker BJ, Branford S, Foroni L, Goldman JM, Muller MC, Radich JP, Rudoltz M, Mone M, Gathmann I, Hughes TP, Larson RA: Sixyear follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia 2009; 23: 1054-1061.
4. O'Hare T, Eide CA, Deininger MW: BCRABL kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia. Blood 2007; 110: 2242-2249.
5. Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F, Deininger MW, Fischer T, O'Brien SG, Stone RM, Gambacorti-Passerini CB, Russell NH, Reiffers JJ, Shea TC, Chapuis B, Coutre S, Tura S, Morra E, Larson RA, Saven A, Peschel C, Gratwohl A, Mandelli F, Ben-Am M, Gathmann I, Capdeville R, Paquette RL, Druker BJ: Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood 2002; 99: 3530-3539. (Pubitemid 34534519)
6. Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F, Schiffer CA, Fischer T, Deininger MW, Lennard AL, Hochhaus A, Ottmann OG, Gratwohl A, Baccarani M, Stone R, Tura S, Mahon FX, Fernandes-Reese S, Gathmann I, Capdeville R, Kantarjian HM, Sawyers CL: Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood 2002; 99: 1928-1937. (Pubitemid 34525471)
7. Schmidt T, Karsunky H, Gau E, Zevnik B, Elsasser HP, Moroy T: Zinc finger protein Gfi-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene 1998; 17: 2661-2667.
8. Zornig M, Schmidt T, Karsunky H, Grzeschiczek A, Moroy T: Zinc finger protein Gfi-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene 1996; 12: 1789-1801.
9. Yucel R, Karsunky H, Klein-Hitpass L, Moroy T: The transcriptional repressor Gfi1 affects development of early, uncommitted ckit + T cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med 2003; 197: 831-844.
10. Hock H, Hamblen MJ, Rooke HM, Traver D, Bronson RT, Cameron S, Orkin SH: Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity 2003; 18: 109-120.
11. Karsunky H, Zeng H, Schmidt T, Zevnik B, Kluge R, Schmid KW, Duhrsen U, Moroy T: Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor gfi1. Nat Genet 2002; 30: 295-300.
12. Person RE, Li FQ, Duan Z, Benson KF, Wechsler J, Papadaki HA, Eliopoulos G, Kaufman C, Bertolone SJ, Nakamoto B, Papayannopoulou T, Grimes HL, Horwitz M: Mutations in proto-oncogene Gfi1 cause human neutropenia and target ELA2. Nat Genet 2003; 34: 308-312.
13. Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, Fujiwara Y, Orkin SH: Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 2004; 431: 1002-1007.
14. Zeng H, Yucel R, Kosan C, Klein-Hitpass L, Moroy T: Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. Embo J 2004; 23: 4116-4125.
15. Vassen L, Khandanpour C, Ebeling P, Van Der Reijden BA, Jansen JH, Mahlmann S, Duhrsen U, Moroy T: Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia. Int J Hematol 2009; 89: 422-430.
16. Basu S, Liu Q, Qiu Y, Dong F: Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. Proc Natl Acad Sci USA 2009; 106: 1433-1438.
17. Duan Z, Zarebski A, Montoya-Durango D, Grimes HL, Horwitz M: Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1. Mol Cell Biol 2005; 25: 10338-10351.